Australian Clinical Labs Ltd (ACL.AX) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Services · Australia · ISIN AU0000148496

Price
3.31 AUD
Market cap
636.65 m AUD
P/E (2026)
26.85
P/S (2026)
0.87
Dividend yield
3.93 %
Net margin
3.25 %
Return on equity (ROE)
15.86 %
Return on assets (ROA)
4.00 %

Australian Clinical Labs Ltd financials

Fiscal year20252026
Revenue741.27 m AUD729.52 m AUD
Gross profit270.86 m AUD150.21 m AUD
Operating income270.86 m AUD61.49 m AUD
EBIT68.00 m AUD61.49 m AUD
Net income32.43 m AUD23.71 m AUD
Diluted EPS – continuing operations0.17 AUD0.12 AUD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Australian Clinical Labs Ltd

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology services. It also provides workplace services, environmental screening, and clinical trial services. The company offers its services under the SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, and Gribbles Veterinary Pathology brands. It serves doctors, patients, and corporate clients. The company was founded in 2015 and is headquartered in Clayton, Australia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.